A Crystal Ball for Cancer Survivors
This test can be thought of as a crystal ball for cancer survivors and research has found it can predict with near certainty whether a patient’s cancer will recur. So why aren't more patients getting the test?
Liquid biopsy highlights from #ASCO2017
Running low on talking points for your liquid biopsy watercooler chats? Fear not. An education session at ASCO 2017 highlighted some of the latest findings from the field — and we have a recap of that recap here.
NEMT Partner Guide: Why Payers and Providers Should Choose MediDrive’s TMS
Alan Murray on improving access for medical transportation.